secwatch / observer
8-K filed January 7, 2025, 6:59 PM ET ticker AWHL CIK 0000926617
leadership confidence high sentiment negative materiality 0.50

Aspira Women's Health interim CFO John Kallassy resigns; CEO becomes principal accounting officer

Aspira Women's Health Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Sandra Milligan

principal accounting officer
AWHL · Aspira Women's Health Inc.
Filed
January 7, 2025, 6:59 PM ET
The Company’s Chief Executive Officer, Dr. Sandra Milligan, will be the Company’s principal accounting officer for the present time.
Departed (interim)

John Kallassy

Interim Chief Financial Officer
AWHL · Aspira Women's Health Inc.
Effective
2025-01-10
Filed
January 7, 2025, 6:59 PM ET
accepted the resignation for personal reasons of John Kallassy, the Company’s Interim Chief Financial Officer, effective on January 10, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Sandra Milligan was appointed as principal accounting officer at Aspira Women's Health Inc..

Action
appointed as principal accounting officer
Role
principal accounting officer
Exact text from the filing
The Company’s Chief Executive Officer, Dr. Sandra Milligan, will be the Company’s principal accounting officer for the present time.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

John Kallassy resigned as Interim Chief Financial Officer at Aspira Women's Health Inc..

Action
resigned
Role
Interim Chief Financial Officer
Exact text from the filing
accepted the resignation for personal reasons of John Kallassy, the Company’s Interim Chief Financial Officer, effective on January 10, 2025.
View on SEC.gov

Aspira Women's Health Inc. filing history →

Source: SEC EDGAR
accession 0001493152-25-001214
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.